Barclays cuts ASML stock rating to equalweight amid muted growth

Barclays downgraded ASML Holding NV from Overweight to Equalweight, lowering the price target to €650 from €770 due to limited near-term catalysts and potential downside risks to the 2026 consensus. The downgrade reflects concerns about muted growth and potential delays in high numerical aperture (NA) technology adoption, despite ASML's reaffirmed revenue guidance for 2025 and a projected revenue CAGR of 11% from 2026 to 2030. While some analysts maintain positive ratings, others have lowered price targets, citing concerns over U.S. tariffs and geopolitical tensions.

Analysis

Barclays has downgraded ASML Holding NV to Equalweight from Overweight, reducing its price target to €650 from €770, citing limited near-term positive catalysts and potential downside risks to the 2026 consensus outlook. This cautious stance is partly attributed to ASML's premium valuation, reflected in its P/E ratio of 29.19, and concerns over muted growth prospects due to unlikely significant customer spending increases from key clients like Samsung or Intel before 2027, alongside customer efficiency gains minimizing tool requirements and potential delays in high numerical aperture (NA) technology adoption. Despite these near-term challenges, InvestingPro data indicates ASML maintains strong fundamentals with 17.67% revenue growth and a prominent position in the semiconductor industry. The company's first-quarter 2025 revenue of €7.74 billion was slightly below expectations, though its earnings per share of €6.00 surpassed forecasts; however, a significant decline in bookings, especially for EUV systems, was observed. ASML has reaffirmed its 2025 revenue guidance of €30-€35 billion and Barclays projects an 11% revenue CAGR for 2026-2030, acknowledging potential near-term volatility. Analyst sentiment is mixed: while TD Cowen, Evercore ISI, and Raymond James remain positive, highlighting market leadership and AI demand, Wells Fargo and Deutsche Bank have lowered price targets, concerned about U.S. tariffs and geopolitical tensions, which could affect ASML's China sales (27% of system sales, projected for a YoY decline in 2025). Management remains optimistic about 2026, and a noted P/E compression might indicate potential value.

Key Decisions for Investors

• Investors should exercise caution in the near term regarding ASML due to the muted growth outlook and potential delays in new technology adoption, as highlighted by Barclays' recent downgrade, despite the company reaffirming its 2025 revenue guidance.
• Closely monitor key catalysts such as semiconductor capital expenditure cycles, particularly from major customers like Samsung and Intel, and the adoption pace of high NA technology, alongside geopolitical developments impacting China sales, which represent 27% of system revenue.
• Long-term investors may find ASML's projected 11% revenue CAGR from 2026-2030 and recent P/E compression attractive, but must weigh this against potential near-term volatility and the mixed sentiment among analysts concerning valuation and external risks like tariffs.